? Project 1 Phenotypic hallmarks of intoxication with seizure-inducing chemical threat agents include: (1) acute hyperexcitation of neural circuits associated with seizures and status epilepticus (SE); and (2) chronic neuroinflammation and neuropathology that manifest subsequent to seizures. Project 1 is using in vitro models essential for elucidating toxicological and therapeutic mechanisms and for discovering intervention strategies that are more effective and safer than current medical countermeasures (atropine, oxime, high-dose benzodiazepines) for treating acute intoxication and protecting against persistent neuropathology. Our focus is on two classes of threat agents: those that block GABAA receptor (GABAAR) function, e.g., tetramethylene- disulfotetramine (TETS) and picrotoxin (PTX, and organophosphates (OP) that inhibit cholinesterases, e.g., diisopropylfluorophosphate (DFP) and paraoxon (PO). Our hypothesis is that in vitro approaches we developed during the first project period can be used to identify, refine and optimize combinatorial therapies that more effectively target TETS- and OP-triggered seizure mechanisms and control subsequent neuroinflammation. This hypothesis will be tested using in vitro and ex vivo rodent models of both sexes.
Aim -1 will determine whether midazolam plus a neurosteroid is more potent than either alone for normalizing TETS and PTX- triggered neuronal network hyperexcitability.
In Aim 2 we will test whether subtype selective nicotinic cholinergic receptor (nAChR) inhibitors are superior to our standard midazolam neurosteroid combination or synergize with it in mitigating OP-triggered seizure-like activity in adult neuron/glia cocultures. Our reasoning is based on the known cholinergic mechanisms of seizure initiation.
Aim 3 will investigate neuroinflammation by evaluating astrogliosis, microglial activation, and neuropathology following exposure to seizure-inducing chemical threat agents and screen for anti-inflammatory compounds that can mitigate these processes. We have developed two cell-based models (astrocyte/microglia and neuron/glia cocultures) from mouse and rat models of both sexes to quantitatively measure differences in neuroinflammation (astrogliosis and microglia activation) and their relationship to neuropathology over acute and prolonged exposures to chemical threat agents. Results obtained from these three aims will be critical for identifying and prioritizing the most promising candidate therapeutics for mitigating seizure-like activity, neuroinflammation and neuropathology to be testedin vivo by Projects 2 and 3.

Agency
National Institute of Health (NIH)
Institute
National Institute of Neurological Disorders and Stroke (NINDS)
Type
Specialized Center--Cooperative Agreements (U54)
Project #
5U54NS079202-09
Application #
9963381
Study Section
Special Emphasis Panel (ZRG1)
Project Start
Project End
Budget Start
2020-06-01
Budget End
2021-05-31
Support Year
9
Fiscal Year
2020
Total Cost
Indirect Cost
Name
University of California Davis
Department
Type
DUNS #
047120084
City
Davis
State
CA
Country
United States
Zip Code
95618
Tu, Ranran; Armstrong, Jillian; Lee, Kin Sing Stephen et al. (2018) Soluble epoxide hydrolase inhibition decreases reperfusion injury after focal cerebral ischemia. Sci Rep 8:5279
Hampe, Alexander E; Li, Zidong; Sethi, Sunjay et al. (2018) A Microfluidic Platform to Study Astrocyte Adhesion on Nanoporous Gold Thin Films. Nanomaterials (Basel) 8:
Hobson, Brad A; Rowland, Douglas J; Supasai, Suangsuda et al. (2018) A magnetic resonance imaging study of early brain injury in a rat model of acute DFP intoxication. Neurotoxicology 66:170-178
Moeller, Benjamin; Espelien, Brenna; Weber, Waylon et al. (2018) The pharmacokinetics of ketamine following intramuscular injection to F344 rats. Drug Test Anal :
Pressly, Brandon; Nguyen, Hai M; Wulff, Heike (2018) GABAA receptor subtype selectivity of the proconvulsant rodenticide TETS. Arch Toxicol 92:833-844
Dhir, Ashish; Rogawski, Michael A (2018) Determination of minimal steady-state plasma level of diazepam causing seizure threshold elevation in rats. Epilepsia 59:935-944
Chapman, Christopher A R; Wang, Ling; Chen, Hao et al. (2017) Nanoporous Gold Biointerfaces: Modifying Nanostructure to Control Neural Cell Coverage and Enhance Electrophysiological Recording Performance. Adv Funct Mater 27:
Wagner, Karen; Gilda, Jennifer; Yang, Jun et al. (2017) Soluble epoxide hydrolase inhibition alleviates neuropathy in Akita (Ins2 Akita) mice. Behav Brain Res 326:69-76
Zhang, Yue; Hong, Gina; Lee, Kin Sing Stephen et al. (2017) Inhibition of soluble epoxide hydrolase augments astrocyte release of vascular endothelial growth factor and neuronal recovery after oxygen-glucose deprivation. J Neurochem 140:814-825
Cao, Zhengyu; Xu, Jian; Hulsizer, Susan et al. (2017) Influence of tetramethylenedisulfotetramine on synchronous calcium oscillations at distinct developmental stages of hippocampal neuronal cultures. Neurotoxicology 58:11-22

Showing the most recent 10 out of 85 publications